Rein Therapeutics, Inc.Rein Therapeutics, Inc.Rein Therapeutics, Inc.

Rein Therapeutics, Inc.

No trades
See on Supercharts

Price target

13.000.000.00%
The 2 analysts offering 1 year price forecasts for RNTX have a max estimate of — and a min estimate of —.

Analyst rating

Based on 2 analysts giving stock ratings to RNTX in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


RNTX EPS for the last quarter is −0.27 USD despite the estimation of −0.25 USD. In the next quarter EPS is expected to reach −0.18 USD. Track more of Rein Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Rein Therapeutics, Inc. revenue is expected to reach 0.00 USD. Check out Rein Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, RNTX price target is 13.00 USD with a max estimate of 19.00 USD and a min estimate of 7.00 USD. Check if this forecast comes true in a year, meanwhile watch Rein Therapeutics, Inc. stock price chart and keep track of the current situation with RNTX news and stock market news.